MoneyWorks4Me

Adinath Bio-Labs submits statement of deviation or variation

13 Jan 2017 Evaluate

Adinath Bio-Labs has submitted the statement of deviation or variation in public issue, right issue, preferential issue etc. for the quarter ended December 31, 2016.

The above information is a part of company’s filings submitted to BSE.

Peers